Christopher A Tam1, Sean P Elliott2, Bryan B Voelzke3, Jeremy B Myers4, Alex J Vanni5, Benjamin N Breyer6, Thomas G Smith7, Christopher D McClung8, Bradley A Erickson9. 1. Department of Urology, University of Iowa, Iowa City, IA. 2. Department of Urology, University of Minnesota, Minneapolis, MN. 3. Department of Urology, University of Washington, Seattle, WA. 4. Division of Urology, University of Utah, Salt Lake City, UT. 5. Lahey Hospital and Medical Center, Institute of Urology, Burlington, MA. 6. Department of Urology, University of California, San Francisco, CA. 7. Department of Urology, Baylor University, Waco, TX. 8. Department of Urology, Ohio State University, Columbus, OH. 9. Department of Urology, University of Iowa, Iowa City, IA. Electronic address: brad-erickson@uiowa.edu.
Abstract
OBJECTIVE: To validate the use of the International Prostate Symptom Score (IPSS) as a stand-alone tool to detect urethral stricture recurrence following urethroplasty. MATERIALS AND METHODS: This study included 393 men who had undergone anterior urethroplasty and were enrolled in a multi-institutional outcomes study. Data analyzed included pre- and post-operative answers to the IPSS in addition to findings from a same- day cystoscopy. IPSS from men found to have cystoscopic recurrence were then compared to scores from those with successful repairs, and receiver operating characteristic curves were plotted to illustrate the predictive ability of these questions to screen for cystoscopic recurrence. RESULTS: Mean postoperative scores were lower (fewer symptoms) in successful repairs; IPSS improved from preoperative values regardless of recurrence. Successful repairs had significantly better degree of improvement in question #5 (assessing weak stream) compared to recurrences. Receiver operating characteristic curves demonstrated the highest area under the curve for the IPSS quality of life question (0.66) that alone outperformed the complete IPSS questionnaire (0.56). CONCLUSION: The IPSS had inadequate sensitivity and specificity to be used as a stand-alone screening tool for stricture recurrence in this large cohort of men, highlighting the need to continue development of a disease-specific, validated patient-reported outcome measure. Published by Elsevier Inc.
OBJECTIVE: To validate the use of the International Prostate Symptom Score (IPSS) as a stand-alone tool to detect urethral stricture recurrence following urethroplasty. MATERIALS AND METHODS: This study included 393 men who had undergone anterior urethroplasty and were enrolled in a multi-institutional outcomes study. Data analyzed included pre- and post-operative answers to the IPSS in addition to findings from a same- day cystoscopy. IPSS from men found to have cystoscopic recurrence were then compared to scores from those with successful repairs, and receiver operating characteristic curves were plotted to illustrate the predictive ability of these questions to screen for cystoscopic recurrence. RESULTS: Mean postoperative scores were lower (fewer symptoms) in successful repairs; IPSS improved from preoperative values regardless of recurrence. Successful repairs had significantly better degree of improvement in question #5 (assessing weak stream) compared to recurrences. Receiver operating characteristic curves demonstrated the highest area under the curve for the IPSS quality of life question (0.66) that alone outperformed the complete IPSS questionnaire (0.56). CONCLUSION: The IPSS had inadequate sensitivity and specificity to be used as a stand-alone screening tool for stricture recurrence in this large cohort of men, highlighting the need to continue development of a disease-specific, validated patient-reported outcome measure. Published by Elsevier Inc.
Authors: J Curtis Nickel; Carlos E Méndez-Probst; Thomas F Whelan; Ryan F Paterson; Hassan Razvi Journal: Can Urol Assoc J Date: 2010-10 Impact factor: 1.862
Authors: Christopher A Tam; Bryan B Voelzke; Sean P Elliott; Jeremy B Myers; Christopher D McClung; Alex J Vanni; Benjamin N Breyer; Bradley A Erickson Journal: Urology Date: 2016-02-10 Impact factor: 2.649
Authors: Matthew J Jackson; John Sciberras; Altaf Mangera; Andrew Brett; Nick Watkin; James M O N'dow; Christopher R Chapple; Daniela E Andrich; Robert S Pickard; Anthony R Mundy Journal: Eur Urol Date: 2011-03-17 Impact factor: 20.096
Authors: Nima Baradaran; Kirkpatrick B Fergus; Rachel A Moses; Darshan P Patel; Thomas W Gaither; Bryan B Voelzke; Thomas G Smith; Bradley A Erickson; Sean P Elliott; Nejd F Alsikafi; Alex J Vanni; Jill Buckley; Lee C Zhao; Jeremy B Myers; Benjamin N Breyer Journal: World J Urol Date: 2019-02-02 Impact factor: 4.226
Authors: Adam Kałużny; Mikołaj Frankiewicz; Jakub Krukowski; Agata Zdun-Ryżewska; Agnieszka Trawicka; Marcin Matuszewski Journal: Cent European J Urol Date: 2019-06-03
Authors: Asma Omran; Bianca M Leca; Eduard Oštarijaš; Natasha Graham; Ana Sofia Da Silva; Zoulikha M Zaïr; Alexander D Miras; Carel W le Roux; Royce P Vincent; Linda Cardozo; Georgios K Dimitriadis Journal: Ther Adv Endocrinol Metab Date: 2021-12-08 Impact factor: 3.565
Authors: Mohamed Rehan; Esam A Elnady; Saed Khater; Ahmed Fawzi Arafat Elsayed; Ahmed M Abdel Gawad; Mohamed Abdel Hafeez Aly Freeg; Alaa R Mahmoud Journal: Medicine (Baltimore) Date: 2022-09-02 Impact factor: 1.817